Operating Expenses Değişiklik Tarih
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Cytokinetics USD 129.09M 6.45M 2023-12
Eisai JPY 171.22B 309M 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Exelixis USD 489.5M 97.5M 2023-09
Genmab DKK 3.03B 326M 2023-09
Incyte USD 826.07M 121.75M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Merck USD 16.56B 6.35B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Takeda JPY 1.09T 202.38B 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Xencor USD 79.7M 2.27M 2023-12



Exelixis Işletim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2024.